Cancer Medicine by Alexandros G.Sfakianakis,Anapafseos 5 Agios Nikolaos,Crete 72100,Greece,tel :00302841026182 & 00306932607174
Πέμπτη 10 Μαΐου 2018
FDA Approves Nivolumab and Ipilimumab Combination for Advanced Kidney Cancer
FDA has approved the combination of two immunotherapy drugs, nivolumab (Opdivo) and ipilimumab (Yervoy), as an initial treatment for some patients with advanced kidney cancer. Learn how this approval will affect patient care.
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου